CPG
COGT icon

Cornerstone Planning Group’s Cogent Biosciences COGT Stock Holding History

Cornerstone Planning Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.7K Hold
100
– – ﹤0.01% 1166
2025
Q4 		$3.84K Hold
100
– – ﹤0.01% 1044
2025
Q3 		$1.62K Hold
100
– – ﹤0.01% 1209
2025
Q2 		$1.14K Hold
100
– – ﹤0.01% 1084
2025
Q1 		$447 Hold
100
– – ﹤0.01% 1332
2024
Q4 		$847 Hold
100
– – ﹤0.01% 995
2024
Q3 		$1.2K Buy
+100
New +$974 ﹤0.01% 898

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Cornerstone Planning Group's COGT Position: Q1 2026 in Review

Cornerstone Planning Group held its Cogent Biosciences (COGT) position steady in Q1 2026 at 100 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Cornerstone Planning Group first reported a position in COGT in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.84K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Cornerstone Planning Group held 100 shares of Cogent Biosciences worth $3.7K as of Q1 2026.
  • Cornerstone Planning Group left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #1166 holding.
  • Cornerstone Planning Group first reported a position in Cogent Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Cornerstone Planning Group's Cogent Biosciences position peaked at $3.84K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.